Peginterferon Is Superior to Nucleos(t)ide Analogues for Prevention of Hepatocellular Carcinoma in Chronic Hepatitis B-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Peginterferon Is Superior to Nucleos(t)ide Analogues for Prevention of Hepatocellular Carcinoma in Chronic Hepatitis B

Published:2015-11-17 Issue:6 Volume:213 Page:966-974
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:J Infect Dis.

Author:

Liang Kung-Hao,Hsu Chao-Wei,Chang Ming-Ling,Chen Yi-Cheng,Lai Ming-Wei,Yeh Chau-Ting

Funder

Chang Gung Memorial Hospital

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/213/6/966/17411627/jiv547.pdf

Reference43 articles.

1. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

2. Liver fibrosis;Bataller;J Clin Invest,2005

3. Hepatitis B: Liver fibrosis and hepatocellular carcinoma

4. Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease

5. Chronic hepatitis B

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Hepatitis B Surface Antigen Levels With Long‐Term Complications in Chronic Hepatitis B Virus Infection: A Systematic Literature Review;Journal of Viral Hepatitis;2024-08-16

2. Interim analysis of the PARADISE study: Benefits of add-on peginterferon-α in NA-treated patients with CHB;Antiviral Research;2024-06

3. Hepatocellular carcinoma surveillance after HBsAg seroclearance;Exploration of Digestive Diseases;2024-05-11

4. Optimal Treatment Based on Interferon No Longer Makes Clinical Cure of Chronic Hepatitis B Far Away: An Evidence‐Based Review on Emerging Clinical Data;Clinical Pharmacology & Therapeutics;2024-04-30

5. Research Progress of Pegylated Interferon Therapy for Chronic HBV Infection;Advances in Clinical Medicine;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3